<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>PhillyPharma</title>
    <link>http://www.philly.com/r?19=960&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma</link>
    <description>RSS feed for PhillyPharma blog.</description>
    <language>en-us</language>
    <copyright />
    <pubDate>Thu, 31 May 2012 11:42:29 GMT</pubDate>
    <dc:creator>David Sell</dc:creator>
    <dc:date>2012-05-31T11:42:29Z</dc:date>
    <dc:language>en-us</dc:language>
    <dc:rights />
    <item>
      <title>Catalent Pharma Solutions says it's selling its Philadelphia packaging operation</title>
      <link>http://www.philly.com/r?19=961&amp;43=982963&amp;44=155902045&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma%2FCatalent-Pharma-Solutions-says-its-selling-its-Philadelphia-packaging-operation.html</link>
      <description>Catalent Pharma Solutions said in a statement that it recently signed a "definitive agreement" to sell its Northeast Philadelphia drug packaging plant and another in Woodstock, Ill., to Frazier Healthcare, a West Coast venture capital firm..</description>
      <pubDate>Thu, 31 May 2012 11:42:29 GMT</pubDate>
      <guid isPermaLink="false">22d81b342b174244caaf418beb6e9b72</guid>
      <dc:creator>David Sell</dc:creator>
      <dc:date>2012-05-31T11:42:29Z</dc:date>
    </item>
    <item>
      <title>Endo lobbying for Lidoderm protection, report says</title>
      <link>http://www.philly.com/r?19=961&amp;43=982963&amp;44=155683095&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma%2FEndo-lobbying-for-protection-report-says.html</link>
      <description>Endo Health Solutions is lobbying both sides of the political aisle for protection of its Lidoderm patch as Congress moves forward with bills to fund the FDA, according to a N.Y. Times report.</description>
      <pubDate>Wed, 30 May 2012 20:55:59 GMT</pubDate>
      <guid isPermaLink="false">a03aeb80ea048f29c0dd4e8501e59382</guid>
      <dc:creator>David Sell</dc:creator>
      <dc:date>2012-05-30T20:55:59Z</dc:date>
    </item>
    <item>
      <title>Blackstone to sell Catalent to Frazier Healthcare, sources say</title>
      <link>http://www.philly.com/r?19=961&amp;43=982963&amp;44=155759555&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma%2FFrazier-Healthcare-to-buy-Catalent-Pharma-Solutions-from-Blackstone.html</link>
      <description>All or part of Catalent Pharma Solutions, with facilities in Northeast Philadelphia and Mount Laurel, is about to be sold by the Blackstone Group to Frazier Healthcare, a West Coast-based venture capital firm, sources said.</description>
      <pubDate>Wed, 30 May 2012 19:50:25 GMT</pubDate>
      <guid isPermaLink="false">0f26f940e9eec4f64185c68c06157377</guid>
      <dc:creator>David Sell</dc:creator>
      <dc:date>2012-05-30T19:50:25Z</dc:date>
    </item>
    <item>
      <title>FDA warns consumers about fake versions of Teva's Adderall</title>
      <link>http://www.philly.com/r?19=961&amp;43=982963&amp;44=155491605&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma%2FFDA-warns-consumers-about-fake-versions-of-Tevas-Adderall.html</link>
      <description>Counterfeit versions of Teva's 30 mg version of Adderall are being peddled on the Internet, so the FDA issued a warning to consumers and health-care professionals.</description>
      <pubDate>Wed, 30 May 2012 13:52:53 GMT</pubDate>
      <guid isPermaLink="false">1509475b6de1211fd87d5f07c3c7e954</guid>
      <dc:creator>David Sell</dc:creator>
      <dc:date>2012-05-30T13:52:53Z</dc:date>
    </item>
    <item>
      <title>Teva says no layoffs now, but new CEO Jeremy Levin alters Americas leadership lineup</title>
      <link>http://www.philly.com/r?19=961&amp;43=982963&amp;44=153629455&amp;32=3796&amp;7=1007848&amp;40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fblogs%2Fphillypharma%2FTeva-says-no-layoffs-now-but-new-CEO-Jeremy-Levin-alters-Americas-leadership-lineup.html</link>
      <description>Teva Pharmaceuticals won't layoff people now, but it is cutting costs and altering its leadership in the United States.</description>
      <pubDate>Thu, 24 May 2012 17:56:31 GMT</pubDate>
      <guid isPermaLink="false">eb7c31071f15d584fb06f0519e670ee3</guid>
      <dc:creator>David Sell</dc:creator>
      <dc:date>2012-05-24T17:56:31Z</dc:date>
    </item>
  </channel>
</rss>


